title: Use of vascular access ports in femoral veins of dogs and cats with cancer.
abstract: OBJECTIVE
  To evaluate long-term function of vascular access ports (VAPs) implanted in the femoral vein of dogs and cats undergoing cancer treatment.
  
  
  METHODS
  Prospective clinical study.
  
  
  METHODS
  3 dogs and 6 cats treated via chemotherapy or radiation.
  
  
  METHODS
  VAPs were surgically implanted in the left femoral vein of 3 dogs and 6 cats over a 1-year period. Injection port location was alternated to either a caudal thoracic or ilial location in each patient. Duration of VAP function, ease of infusion, and ease of aspiration through the VAPs were recorded, and associated complications were assessed at each VAP use. Client satisfaction with VAP placement was evaluated by use of a questionnaire.
  
  
  RESULTS
  Primary uses of the VAPs included blood sampling and delivering sedative or chemotherapeutic drugs. Median duration of successful infusion was 147 days (range, 60 to 370 days), and median duration of successful aspiration was 117 days (range, 10 to 271 days). The frequency of signs of VAP-related discomfort was low (7% of patient observations). Clients were satisfied with their decision to use VAPs. Complications included partial (n = 7) or complete (2) VAP occlusion, port migration (1), and presumptive infection (1).
  
  
  CONCLUSIONS
  Results suggested that VAP implantation into the femoral vein provides an acceptable means of chronic venous access in dogs and cats undergoing cancer treatment.
authors.affiliation: Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853, USA.
authors.forename: Alane Kosanovich
authors.initials: AK
authors.lastname: Cahalane
authors.forename: Kenneth M
authors.initials: KM
authors.lastname: Rassnick
authors.forename: James A
authors.initials: JA
authors.lastname: Flanders
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002371:Cat Diseases / Q000188:drug therapy; D002408:Catheters, Indwelling / Q000009:adverse effects / Q000592:standards / Q000662:veterinary*; D002415:Cats; D004283:Dog Diseases / Q000188:drug therapy; D004285:Dogs; D005260:Female; D005268:Femoral Vein; D008297:Male; D009369:Neoplasms / Q000188:drug therapy / Q000662:veterinary; D011446:Prospective Studies; D013997:Time Factors; D014730:Veterinary Medicine / Q000295:instrumentation* / Q000379:methods*
chemical_list: D000970:Antineoplastic Agents